Visceral Leishmaniasis | Risk of Disease Relapse & Progression in HIV Patient

Gender of the patient

Is the infection caused by a drug-resistant strain?

Does the patient have a history of one or more previous relapses?

Has the patient been compliant with the therapy for VL?

Does the patient take secondary prophylaxis?

Does the patient show persistent anti-Leishmania antibodies?

Does the patient have clinical AIDS?

Does the patient have one or more severe AIDS-related diseases?

Is the patient's CD4 count low (< 200 per µL)?

Was the patient thrombocytopenic at the time of initial diagnosis of VL?

Is the patient receiving HAART?